On April 2, 2026, Private Capital Management, LLC (PCM) filed a Schedule 13G regarding its holdings in Target Hospitality Corp. (TH). The filing indicates that as of March 31, 2026, PCM beneficially owns 5,101,355 shares of Common Stock, representing 5.09% of the company. This reflects an increase from the previously r...

The Capital Management Corporation (VA) has filed a Schedule 13G regarding its holdings in Townsquare Media, Inc. (TSQ). As of the event date on March 31, 2026, the filer reported beneficial ownership of 2,494,607 shares of common stock, representing a significant 14.6% stake in the company. This filing marks a substan...

On April 1, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G disclosing a new 5.2% ownership stake in Wix.com Ltd. (WIX). The reporting group beneficially owns 3,028,326 ordinary shares, with an estimated market value of approximately $274 million based on r...

On March 27, 2026, Acorn Bioventures and its affiliated entities disclosed a significant new position in OnKure Therapeutics, Inc. (OKUR). The filing, submitted via Schedule 13G, reveals that Acorn Bioventures 2, L.P. and Acorn Capital Advisors GP 2, LLC beneficially own 2,069,512 shares of common stock, representing a...

On April 1, 2026, a group of reporting entities led by Soleus Private Equity Fund III, L.P. and managed by Guy Levy filed a Schedule 13G regarding their holdings in Aprea Therapeutics, Inc. (APRE). The filing reveals a new beneficial ownership position of 1,271,080 shares of common stock, representing 9.99% of the comp...

On April 1, 2026, Logos Global Management LP and its affiliates, including Logos Global Master Fund LP and Dr. William Arsani, filed a Schedule 13G regarding their stake in Avalo Therapeutics, Inc. (AVTX). The reporting group disclosed beneficial ownership of 1,285,000 shares of Common Stock, representing a 5.6% owners...

On April 1, 2026, Blackstone Holdings II L.P. and associated reporting persons, including Stephen A. Schwarzman and Blackstone Inc., filed a Schedule 13G regarding their holdings in Battalion Oil Corporation (BATL). The filing serves as an exit statement, indicating that the reporting persons no longer beneficially own...

Samuel W. Weatherford and Gordon Scharf have filed a joint Schedule 13G regarding their holdings in Black Rock Coffee Bar, Inc. Samuel W. Weatherford reports beneficial ownership of 3,415,380 shares of Class A Common Stock, representing a 16.3% stake. This ownership is derived from LLC Units in Black Rock Coffee Holdin...

On April 1, 2026, Blackstone Holdings II L.P. and associated reporting persons, including Stephen A. Schwarzman and Blackstone Inc., filed a Schedule 13G regarding their holdings in Battalion Oil Corporation (BATL). The filing serves as an exit statement, indicating that the reporting persons no longer beneficially own...

On April 1, 2026, Voss Capital, LP, along with affiliated entities and Travis W. Cocke, filed a Schedule 13G reporting a new 5.04% stake in Centerspace (CSR). The reporting group beneficially owns an aggregate of 846,246 common shares. Specifically, Voss Value Master Fund, L.P. holds 150,000 shares (0.89%), Voss Value-...

On April 1, 2026, Darlington Partners Capital Management, LP, along with its affiliates, filed a Schedule 13G reporting a new 5.1% ownership stake in Warner Music Group Corp. (WMG). The reporting group includes Darlington Partners GP, LLC, Darlington Partners, L.P., Scott W. Clark, and Ramsey B. Jishi. Collectively, th...

Glenbrook Capital Management (GCM) has filed a Schedule 13G disclosing a new 8.33% stake in INVO Fertility, Inc. (IVF). As of the event date on March 25, 2026, the Nevada-based investment manager reported beneficial ownership of 134,515 shares of Common Stock. This position was established from a previous zero-holding ...

Glenbrook Capital Management (GCM) has filed a Schedule 13G disclosing a new 8.33% stake in INVO Fertility, Inc. (IVF). As of the event date on March 25, 2026, the Nevada-based investment manager reported beneficial ownership of 134,515 shares of Common Stock. This position was established from a previous zero-holding ...

On April 1, 2026, Logos Global Management LP and its affiliates, including Logos Global Master Fund LP and Dr. William Arsani, filed a Schedule 13G regarding their stake in Avalo Therapeutics, Inc. (AVTX). The reporting group disclosed beneficial ownership of 1,285,000 shares of Common Stock, representing a 5.6% owners...

On March 31, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G regarding their holdings in PennyMac Financial Services, Inc. (PFSI). The filing reports that as of March 27, 2026, the reporting persons reached a beneficial ownership position of 2,535,760 share...

On March 31, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G with the SEC, reporting a combined ownership of 2,288,570 shares of Omnicell, Inc. (OMCL). This position represents a 5.0% ownership stake in the company's common stock. The event triggering this ...

On April 1, 2026, MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G disclosing a new 6.0% ownership stake in QDRO Acquisition Corp. (QADR). The reporting entities collectively hold 1,500,000 Class A Ordinary Shares. The event triggering this filing occurred on March 27, 2026. According to t...

Paradigm BioCapital Advisors LP, along with its affiliates Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd., filed a Schedule 13G on April 1, 2026, disclosing a new 6.1% stake in Maze Therapeutics, Inc. (MAZE). The reporting group collectively beneficially owns 3,...

On March 31, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G with the SEC, reporting a combined ownership of 2,288,570 shares of Omnicell, Inc. (OMCL). This position represents a 5.0% ownership stake in the company's common stock. The event triggering this ...

On March 27, 2026, Acorn Bioventures and its affiliated entities disclosed a significant new position in OnKure Therapeutics, Inc. (OKUR). The filing, submitted via Schedule 13G, reveals that Acorn Bioventures 2, L.P. and Acorn Capital Advisors GP 2, LLC beneficially own 2,069,512 shares of common stock, representing a...

Paradigm BioCapital Advisors LP, along with its affiliates Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd., filed a Schedule 13G on April 1, 2026, disclosing a new 6.1% stake in Maze Therapeutics, Inc. (MAZE). The reporting group collectively beneficially owns 3,...

On March 31, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G regarding their holdings in PennyMac Financial Services, Inc. (PFSI). The filing reports that as of March 27, 2026, the reporting persons reached a beneficial ownership position of 2,535,760 share...

On April 1, 2026, Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen filed a Schedule 13G regarding their holdings in Vera Therapeutics, Inc. (VERA). The filing discloses a combined beneficial ownership of 1,229,525 shares of Class A Common Stock, representing 1.7% of the class. This po...

On April 1, 2026, MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G disclosing a new 6.0% ownership stake in QDRO Acquisition Corp. (QADR). The reporting entities collectively hold 1,500,000 Class A Ordinary Shares. The event triggering this filing occurred on March 27, 2026. According to t...

On April 1, 2026, Soleus Capital Master Fund, L.P., along with its affiliates and Guy Levy, filed a Schedule 13G reporting a new 5.0% passive ownership stake in Vericel Corp (VCEL). The reporting group beneficially owns 2,549,079 shares of common stock as of the event date of March 31, 2026. The filing indicates that S...